Cautionary Statements Regarding Forward-Looking Information

This web site contains forward-looking statements. Such forward-looking statements can be identified by the use of the words "expect," "believe," "will," "anticipate," "estimate," "plan," "project" and other words of similar import. The forward-looking statements on this web site include, but are not limited to, statements related to the potential of clinical candidates as therapeutic options for various cancers, the general development of candidate product pipelines and anticipated milestone dates, and possible effects of the approach to cancer treatment. These forward-looking statements are based on current plans of Biobohemia, Inc, objectives, estimates, expectations, and intentions, and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks and uncertainties associated with immuno-oncology product development and clinical success thereof, the uncertainty of regulatory approval, and other risks and uncertainties affecting companies and their development programs. Other risks and uncertainties of which Biobohemia, Inc are not currently aware may also affect the forward-looking statements of Biobohemia, Inc. The forward-looking statements herein are made only as of the date hereof. Biobohemia, Inc on this web site undertake no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, altered expectations, or other circumstances that exist after the date on which the forward-looking statements were made. There are no public offers on this web site.

For greater certainty, Biobohemia, Inc is not making any express or implied claims that it can treat cancer at this time.